Division News

Dorothy Sipkins, MD, PhD, will present her research at the Department's Medicine Research Seminar Series on Friday, April 27, 2018 in Duke Hospital Room 2002.

Department of Medicine faculty, trainees and staff received seven of 10 2018 DIHI Innovation Awards, which support high-potential care delivery innovation projects in the areas of population health and analytics, novel patient interactions, new and team-based models of care, and optimization of patient flow.

Ned Sharpless, MD, director of the National Cancer Institute, will present at Medicine Grand Rounds on Fri., March 23 at 8 a.m. in Duke North Room 2002.

After taking care of pediatric cancer patients in Tanzania, Kristin Schroeder, MD, MPH, and Nelson Chao, MD, MBA, established the International Cancer Care and Research Excellence Foundation (iCCARE) in 2014, a nonprofit whose mission is to give any child diagnosed with cancer the same chance of a cure regardless of where they live. Funded primarily through individual donations, iCCARE covers treatment costs for BMC pediatric cancer patients and provides other resources and support, including a hostel where they and their families can stay while receiving treatment.

Jennifer Frith, nurse manager, operations of Adult Blood and Marrow Transplant Clinic is Duke Today's Blue Devil of the week.

Anthony Sung, MD, assistant professor of medicine (Hematologic Malignancies and Cellular Therapy), and Lawrence David, PhD, assistant professor of molecular genetics and microbiology, have received a 2018 Damon Runyon-Rachleff Innovation Award from the Damon Runyon Cancer Research Foundation.

Duke study, led by Keith Sullivan, MD, shows stem cell transplant is better than drug therapy for scleroderma. The research was published in the New England Journal of Medicine on Jan. 4.

7 faculty from the Department of Medicine will participate in the School of Medicine's LEADER program.

Department of Medicine faculty are attending the American Society of Hematology's (ASH) 59th Annual Meeting & Exposition in Atlanta this week. Keep reading for highlights on their research.

Dorothy Sipkins, MD, PhD, is a hematologist-oncologist who studies cancer. But to understand the cleverness of her work, it’s helpful to think of her as an ecologist—a cell ecologist.

Sipkins identifies very specific biological habitats and interactions that allow malignant cells to move, proliferate and survive chemical attacks, traits that too often produce fatal disease.

“I love thinking about what is on the outside of the cell. What the cell is seeing. What the cell is interacting with, the 3-D environment it interacts with,” says Sipkins.